CISOA
EW icon

Capital Investment Services of America’s Edwards Lifesciences EW Stock Holding History

Capital Investment Services of America’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,148
Closed -$278K – 76
2022
Q1 		$278K Hold
2,148
– – 0.03% 70
2021
Q4 		$278K Hold
2,148
– – 0.03% 70
2021
Q3 		$243K Hold
2,148
– – 0.02% 74
2021
Q2 		$222K Buy
+2,148
New +$202K 0.02% 82

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Investment Services of America's EW Position: Q2 2022 in Review

Capital Investment Services of America sold out of Edwards Lifesciences (EW) in Q2 2022, closing a stake of 2,148 shares — an estimated $278K sold.

Capital Investment Services of America first reported a position in EW in Q2 2021 and held it in 4 quarters. The position peaked at $278K in Q1 2022. 1,273 funds tracked by Wall St. Rank hold EW as of Q2 2022.

  • Capital Investment Services of America reported no remaining Edwards Lifesciences position as of Q2 2022 after selling out during the quarter.
  • Capital Investment Services of America sold 2,148 Edwards Lifesciences shares in Q2 2022, an estimated $278K.
  • Capital Investment Services of America first reported a position in Edwards Lifesciences in Q2 2021 and held it in 4 quarters.
  • Capital Investment Services of America's Edwards Lifesciences position peaked at $278K in Q1 2022.
  • 1,273 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2022.

Based on Capital Investment Services of America's 13F filing for Q2 2022, filed 5 Jul 2022.